Список литературы
Krammer F., Simon V. Serology assays to manage COVID-19. Science. 2020; 368: 1060-1. https://doi.org/10.1126/science.abc1227
Alter G., Seder R. The power of antibody-based surveillance. The New England Journal of Medicine. 2020; 383: 1782-4. https://doi.org/10.1056/NEJMe2028079
Abu Jabal K., Ben-Amram H., Beiruti K., Batheesh Y., Sussan C., Zarka S. et al. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the bnt162b2 mrna COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, december 2020 to january 2021. Eurosurveillance. 2021; 26(6): 2100096. https://doi.org/10.2807/1560-7917.ES.2021.26.6.2100096
Prendecki M., Clarke C., Brown J., Cox A., Gleeson S., Guckian M. et al. Effect of previous SARS-CоV-2 infection on humoral and t-cell responses to single-dose bnt162b2 vaccine. Lancet. 2021; 397(10280): 1178-81. https://doi.org/10.1016/S0140-6736(21)00502-X
Jin P., Li J., Pan H., Wu Y., Zhu F. Immunological surrogate endpoints of covid-2019 vaccines: The evidence we have versus the evidence we need. Signal Transduction and Targeted Therapy. 2021; 6: 48. https://doi.org/10.1038/s41392-021-00481-y
McMahan K., Yu.J., Mercado N.B., Loos C., Tostanoski L.H., Chandrashekar A. et al. Correlates of protection against SARS-COV-2 in rhesus macaques. Nature. 2021; 590(7847): 630-4. https://doi.org/10.1038/s41586-020-03041-6
Perkmann T., Perkmann-Nagele N., Breyer M.K., Breyer-Kohansal R., Burghuber O.C., Hartl S. et al. Side-by-side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity. Clinical Chemistry. 2020; 66: 1405-13. https://doi.org/10.1093/clinchem/hvaa198
Pollan M., Perez-Gomez B., Pastor-Barriuso R., Oteo J., Hernan M.A., Perez-Olmeda M. et al. Prevalence of SARS-COV-2 in spain (ene-COVID): A nationwide, population-based seroepidemiological study. Lancet. 2020; 396: 535-44. https://doi.org/10.1016/S0140-6736(20)31483-5
Oved K., Olmer L., Shemer-Avni Y., Wolf T., Supino-Rosin L., Prajgrod G. et al. Multi-center nationwide comparison of seven serology assays reveals a SARS-CоV-2 non-responding seronegative subpopulation. E Clinical Medicine. 2020; 29: 100651. https://doi.org/10.1016/j.eclinm.2020.100651
Long Q.X., Tang X.J., Shi Q.L., Li Q., Deng H.J., Yuan J. et al. Clinical and immunological assessment of asymptomatic SARS-CоV-2 infections. Nature Medicine. 2020; 26: 1200-4. https://doi.org/10.1038/s41591-020-0965-6
Lumley S.F., Wei J., O’Donnell D., Stoesser N.E., Matthews P.C., Howarth A. et al. The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers. Clinical Infection Diseases. 2021; 73(3): e699-e709. https://doi.org/10.1093/cid/ciab004
Muecksch F., Wise H., Batchelor B., Squires M., Semple E., Richardson C. et al. Longitudinal analysis of serology and neutralizing antibody levels in COVID-19 convalescents. The Journal of Infectious Diseases. 2020; 223 (3). https://doi.org/10.1101/2020.08.05.20169128
Robbiani D.F., Gaebler C., Muecksch F., Lorenzi J.C.C., Wang Z., Cho A. et al. Convergent antibody responses to SARS-CоV-2 in convalescent individuals. Nature. 2020; 584: 437-42. https://doi.org/10.1038/s41586-020-2456-9
Buss L.F., Prete C.A.Jr., Abrahim C.M.M., Mendrone A.Jr., Salomon T., de Almeida-Neto C. et al. Three-quarters attack rate of SARS-CоV-2 in the brazilian amazon during a largely unmitigated epidemic. Science. 2021; 371: 288-92. https://doi.org/10.1126/science.abe9728
Bolotin S., Tran V., Osman S., Brown K.A., Buchan S.A., Joh E. et al. SARS-CоV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline. Journal of the Infectious Diseases. 2021; 223(8): 1334-8. https://doi.org/10.1093/infdis/jiaa796
Favresse J., Brauner J., Bodart N., Vigneron A., Roisin S., Melchionda S. et al. An original multiplex method to assess five different SARS-CоV-2 antibodies. Clinical chemistry and laboratory medicine. 2020; 59(5): 971-8. https://doi.org/10.1515/cclm-2020-1652
Le Bert N., Tan A.T., Kunasegaran K., Tham C.Y.L., Hafezi M., Chia A. et al. SARS-CоV-2-specific t cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020; 584: 457-62. https://doi.org/10.1038/s41586-020-2550-z
Musico A., Frigerio R., Mussida A., Barzon L., Sinigaglia A., Riccetti S. et al. SARS-CоV-2 epitope mapping on microarrays highlights strong immune-response to n protein region. Vaccines (Basel). 2021; 9(1): 35. https://doi.org/10.3390/vaccines9010035
Klausberger M., Dürkop M., Haslacher H., Wozniak-Knopp G., Cserjan-Puschmann M., Perkmann T. et al. A comprehensive antigen production and characterization study for easy-to-implement, highly specific and quantitative SARS-CoV-2 antibody assays. EBioMedicine. 2021; 67: 103348. https://doi.org/10.1101/2021.01.19.21249921
Wajnberg A., Amanat F., Firpo A., Altman D.R., Bailey M.J., Mansour M. et al. Robust neutralizing antibodies to SARS-CоV-2 infection persist for months. Science. 2020; 370: 1227-30. https://doi.org/10.1126/science.abd7728
Bal A., Pozzetto B., Trabaud M.A., Escuret V., Rabilloud M., Langlois-Jacques C. et al. Evaluation of high-throughput SARS-CоV-2 serological assays in a longitudinal cohort of patients with mild COVID-19: Clinical sensitivity, specificity and association with virus neutralization test. Clinical Chemistry. 2021; 67(5): 742-52. https://doi.org/10.1093/clinchem/hvaa336
Bonelli F., Sarasini A., Zierold C., Calleri M., Bonetti A., Vismara C. et al. Clinical and analytical performance of an automated serological test that identifies s1/s2-neutralizing igg in COVID-19 patients semiquantitatively. Journal of Clinical Microbiology. 2020; 58(9): e01224-20. https://doi.org/10.1128/JCM.01224-20
Padoan A., Bonfante F., Pagliari M., Bortolami A., Negrini D., Zuin S. et al. Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity. EBioMedicine. 2020; 62: 103101.
Patel E.U., Bloch E.M., Clarke W., Hsieh Y.H., Boon D., Eby Y. et al.Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers. Journal Clinical Microbiology. 2021; 59(2): e02257-20. https://doi.org/10.1128/JCM.02257-20
Suhandynata R.T., Hoffman M.A., Huang D., Tran J.T., Kelner M.J., Reed S.L. et al.Commercial serology assays predict neutralization activity against SARS-CоV-2. Clinical Chemistry. 2021; 67(2): 404-14. https://doi.org/10.1093/clinchem/hvaa262
Tang M.S., Case J.B., Franks C.E., Chen R.E., Anderson N.W., Henderson J.P. et al. Association between SARS-CoV-2 neutralizing antibodies and commercial serological assays. Clinical Chemistry. 2020; 66(12): 1538-47. https://doi.org/10.1093/clinchem/hvaa211
Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020; 586(7830): 516-27. https://doi.org/10.1038/s41586-020-2798-3
Nie J., Li Q., Wu J., Zhao C., Hao H., Liu H. et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerging Microbes Infections. 2020; 9: 680-6. https://doi.org/10.1080/22221751.2020.1743767
Oguntuyo K.Y., Stevens C.S., Hung C.T., Ikegame S., Acklin J.A., Kowdle S.S. et al. Quantifying absolute neutralization titers against SARS-CоV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of covid-19 sera. mBio; 2021; 12(1): e02492-20. https://doi.org/10.1128/mBio.02492-20
Марданлы С.Г. Разработка и испытания новых иммуноферментных тест систем для диагностики токсоплазмоза. Клиническая лабораторная диагностика. 2009; 2: 35-7.
Марданлы С.Г., Симонов В.В., Авдонина А.С. Производство наборов реагентов для клинической лабораторной диагностики иммунохимическими методами. Орехово-Зуево: ГГТУ; 2017.
Марданлы С.Г., Симонова Е.Г., Симонов В.В. Инфекции TоRCH-группы: клиническая лабораторная диагностика, эпидемиологический надзор и контроль. Москва: Транзит-ИКС; 2018.
Марданлы С.Г., Симонова Е.Г., Симонов В.В. Герпесвирусные инфекции: этиология и патогенез, клиника и лабораторная диагностика, эпидемиология и профилактика. Орехово-Зуево: ГГТУ; 2020.
Марданлы С.Г., Авдонина А.С. Мамедова С.Г. Разработка иммуноферментной тест-системы для выявления антител класса IgG к возбудителю COVID-19 в сыворотке (плазме) крови человека. Клиническая лабораторная диагностика. 2020; 65(11): 683-7. https://doi.org/10.18821/0869-2084-2020-65-11-683-687